Bisphosphonate-related osteonecrosis of the jaw: an overview.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 20946580)

Published in Ann N Y Acad Sci on September 28, 2010

Authors

Salvatore L Ruggiero1

Author Affiliations

1: Department of Oral and Maxillofacial Surgery, School of Dental Medicine, SUNY at Stony Brook, Stony Brook, New York, USA. sruggie@optonline.net

Articles citing this

Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res (2012) 1.73

Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis (2011) 0.96

Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies. Osteoporos Int (2012) 0.92

Bisphosphonate-related osteonecrosis of the jaws: legal liability from the perspective of the prescribing physician. J Bone Miner Metab (2013) 0.89

Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci (2011) 0.86

Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data. Clin Investig (Lond) (2011) 0.86

Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap. Clin Oral Investig (2011) 0.85

Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg (2015) 0.84

Local bisphosphonate release versus hydroxyapatite coating for stainless steel screw fixation in rat tibiae. J Mater Sci Mater Med (2011) 0.84

Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws. Trauma Mon (2014) 0.84

Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int (2014) 0.83

Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease. Rheumatol Int (2013) 0.81

Implications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Nucl Med Mol Imaging (2012) 0.80

Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice. Tissue Eng Part A (2013) 0.78

Effect of bisphosphonates on orthodontic tooth movement-an update. J Clin Diagn Res (2015) 0.78

Intravenous bisphosphonate-related osteonecrosis of the jaws: influence of coadjuvant antineoplastic treatment and study of buccodental condition. Med Oral Patol Oral Cir Bucal (2013) 0.77

Bisphosphonate related osteonecrosis of the jaws: report of two cases. Imaging Sci Dent (2011) 0.77

Osteonecrosis of the jaws in patients treated with bisphosphonates. J Clin Exp Dent (2012) 0.76

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats. J Oral Maxillofac Res (2016) 0.75

Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. PLoS One (2015) 0.75

Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities. Int J Clin Exp Pathol (2014) 0.75

Current state of orthodontic patients under bisphosphonate therapy. Head Face Med (2013) 0.75

CORR Insights(®): development of a mouse model of ischemic osteonecrosis. Clin Orthop Relat Res (2015) 0.75

Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates. BMJ Case Rep (2012) 0.75

Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep (2015) 0.75

Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs. Front Chem (2017) 0.75

Managing bisphosphonate-related osteonecrosis of the jaws with xenografts: a case report. Clin Case Rep (2017) 0.75

BRONJ-related jaw bone is associated with increased Dlx-5 and suppressed osteopontin-implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates. Clin Oral Investig (2014) 0.75